Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Transcripts
  • inderesTV
  • Portfolio
  • Forum
  • Q&A
  • About Us
    • Our Coverage
    • Team
Press release

Redeye: Vitrolife - Pressure on Growth and Margins

Vitrolife

APAC and Consumables delivers another strong quarter with double digit growth. Vitrolife continues to experience pressure on the Genetic Services business and especially in US. Some of these challenges can be expected to remain for some time. The weakness is the Technology Business is more likely to be temporary. We can expect a near term period of more modest growth and stable margins. The consumable busies and the APAC regions probably need to compensate with a solid performance also during H2 2023E. Our updated view is a base case valuation of SEK 265 (295) and a Bull Case of SEK 415 (425), and a Bear Case of SEK 130 (140). A near term balancing act.

Read more and download the Research Update.

Follow companies at Redeye to receive the latest equity research within Life Science and Technology.

This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/

Attachments


Vitrolife - Pressure on Growth and Margins

Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.